Colchicine for Peripheral Artery Disease

We are studying whether a low dose of colchicine can help reduce serious heart and limb problems in patients with peripheral artery disease. This research aims to improve safety and outcomes for those affected.

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Who can participate in the clinical trial?

These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..

What medicines are being studied?

Medicines that are officially approved for use in the European Union and considered safe by EMA. These medicines are already on the market and may be tested for new conditions or populations.

Colchicine Tiofarma
Colchicine Tiofarma is a medicine used to treat and prevent gout attacks and certain inflammatory disorders.

What active substances are being studied?

Active substances that are officially approved for use in the European Union and considered safe by EMA. These substances are already on the market and may be tested for new conditions or populations.

Colchicine
Colchicine is a substance that reduces inflammation to treat and prevent gout attacks.

What experimental substances are being tested?

Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.

Colchicine

What similar medicines might you know?

Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.

Colcamedin
Colcamexx
Colchanova

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
UZ Leuven
Cardiology
Heverlee, Belgium
Azienda Unita Locale Socio Sanitaria N. 1 Dolomiti
Cardiology
Belluno, Italy
Azienda Unita' Locale Socio Sanitaria N. 2 Marca Trevigiana
Cardiology
Castelfranco Veneto, Italy

Sponsor: Hamilton Health Sciences Corporation
Last updated: Nov 27, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.